$0.16
+0.00 (+1.91%)
Analyst Consensus
Strong Buy
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+14,158.1% upside
Low Target
$15.13
Average Target
$22.10
High Target
$31.02
Current Price
$0.16
Current
$0.16
$0.16
Target
$22.10
$22.10
$15.13
$22.10 avg
$31.02
Scenario Analysis
Bear Case
$15.13
9,661.3%
Low target
Base Case
$22.10
+14,158.1%
Avg target
Bull Case
$31.02
+19,912.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$1.96
-92.1% from high
52-Week Low
$0.15
+3.1% from low
Target vs 52W High
$22.10
+1,027.6% vs high
Next Earnings Report
Nov 16, 2026
8d
until earnings
EPS Est: $-0.14
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |